Closing the gap: prognostic and predictive biomarker validation for personalized care in a Latin American hormone-dependent breast cancer cohort
D Alves da Quinta, D Rocha, J Retamales… - The …, 2024 - academic.oup.com
Background Several guidelines recommend the use of different classifiers to determine the
risk of recurrence (ROR) and treatment decisions in patients with HR+ HER2− breast cancer …
risk of recurrence (ROR) and treatment decisions in patients with HR+ HER2− breast cancer …
[PDF][PDF] Molecular Mechanisms And Therapeutic Challenges In Breast Cancer Progression And Metastasis
Background: Breast cancer is the most common oncological condition in women worldwide.
The mortality rate due to breast cancer is rising, particularly in advanced stages where the …
The mortality rate due to breast cancer is rising, particularly in advanced stages where the …